Viewing profile — bedast

As noted in the article, it bans the app from the app stores, not individual devices. It doesn't penalize individuals for having and using the app.

I have my own domain attached to icloud mail at the moment. But primarily, I have my own domain and can move it to wherever I need it. Icloud mail isn't the best thing in the world…

I'm frequently reminding people that Google is not an email provider nor a search engine nor really anything else it pretends to be, but that it's a data harvesting and ad company.…

Sometimes it's not just about getting rid of an annoyance. I've stuck to my guns with ad blocking to protect myself from malicious ad content. In terms of content creators getting …

Reading the article, I failed to see what link they found. The headline here matches the one on the article so I'm not calling that into question, but what seems to be more accurat…

In my experience, the White Ambiance lights don't get as dim as the other Hue bulbs. In places where I wanted even lower light, I've had to use their White Ambiance Filament or Col…

I've noticed the White Ambiance lights don't dim to a very low level for night time night light type of use, but the White and Color Ambiance bulbs can get far dimmer. Also the Whi…

I have a box of batteries I need to dispose of that I haven't just tossed in the garbage. My local Home Depot used to take batteries, but only non-lithium ion batteries. And someti…

I feel like there's not enough easily accessible information in the wild about what you're supposed to do with old electronics, and especially batteries. You're not supposed to thr…

The article notes that, yes, he will remain as spokesperson.

You might get a good few years from the drug. You have to still do the work to make the changes permanent.

In my experience, if you're going to use GLP-1 RA for weight loss, it needs to be part of a larger program of changes, including lifestyle changes. That you have to lead the charge…

Mounjaro will never be approved for obesity. The documentation for dosing is for diabetes. If the trend follows with how Novo Nordisk has released their versions of this, dosing fo…

This is not only an American issue. I've seen people in the UK struggle to get access to treatments and devices through the NHS. Canada tends to follow what the US is doing even th…

Do you even know what A1c is? Or how GLP-1 RA achieves this goal? GLP-1 RA does NOT achieve a reduced A1c through weight loss. It achieves improved glycemic control by slowing the …

Tirzepatide is in testing. The weight loss variant will not be called Mounjaro. If they follow similar patterns from Novo Nordisk with Saxenda and Wegovy, dosing will be different …

You are among the people just learning about this class of drug. It's been around since 2004 (Byetta). I've been taking it since 2012 (Victoza). Even then, it was known to promote …

Significantly increasing production for a temporary benefit is going to require significant investment. Since it is a temporary benefit, it's probably not worth that significant in…

They also probably don't want to put significant investment in boosting production knowing that will be temporary since the weight loss effects aren't permanent. As someone who has…

Brand new drugs tend to take a while to get on insurance formularies. I believe Mounjaro is still missing in most formularies. Lilly wants people on their drug, not the competition…

Allowing the coupon to be used for the treatment of obesity is an implicit approval for the drug to be used in this way, and coupons are a form of marketing. Lilly cannot approve n…

> That it is currently labeled only for Type 2 diabetes is a marketing decision by the manufacturer, not a characteristic of the drug. Regulatory approval. It is a diabetes drug be…

I care that many people I know are losing glycemic control because they're going on a waiting list for their medication while Kim K and Elon Musk and TikTok promote easy mode cosme…

And dose. The doses are different. You need a much higher dose than is typically prescribed for diabetes to get the full weight loss benefits. Part of getting approval for on-label…

Yes, this is what Novo Nordisk did with Victoza around 2014 with the release of Saxenda. And then again with Ozempic around 2021 with Wegovy. These weight loss versions exist. And …